Jim Simons Candel Therapeutics, Inc. Transaction History

Renaissance Technologies LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	SELL	$1.68 - $14.0 $60,992 - $508,270	-36,305 Reduced 63.8%	20,600 $127,000
Q1 2024 May 13, 2024	BUY	$1.21 - $1.86 $46,258 - $71,107	38,230 Added 204.71%	56,905 $90,000
Q4 2023 Feb 13, 2024	BUY	$0.68 - $1.47 $12,699 - $27,452	18,675 New	18,675 $27,000
Q2 2023 Aug 11, 2023	SELL	$1.2 - $1.78 $9,840 - $14,596	-8,200 Reduced 39.05%	12,800 $16,000
Q1 2023 May 12, 2023	BUY	$1.35 - $2.72 $28,350 - $57,120	21,000 New	21,000 $28,000

6.41M

109K

130K

Ticker CADL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,891,900
Market Cap $256M
Description
Candel Therapeutics, Inc., a clinical stage biopharmaceutical company, engages in the development immunotherapies for the cancer patients. The company develops CAN-2409, which is in Phase II clinical trails for the treatment of pancreatic cancer; Phase III clinical trials for the treatment of prostate cancer; and Phase II clinical trials for the...

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.